Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Johnson and Johnson
Cantor Fitzgerald
Federal Trade Commission
Merck

Generated: March 25, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Crenezumab

« Back to Dashboard

US Patents for Crenezumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Crenezumab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Crenezumab ➤ Sign Up Bispecific chimeric antigen receptors and methods of use thereof to treat cancer Seattle Children's Hospital (Seattle, WA) ➤ Sign Up
Crenezumab ➤ Sign Up Method and composition for hyperthermally treating cells ➤ Sign Up
Crenezumab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Crenezumab ➤ Sign Up Detection of misfolded amyloid beta protein AMPRION, INC. (San Diego, CA) THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, TX) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Crenezumab

Drugname Country Document Number Estimated Expiration Related US Patent
Crenezumab Australia 2013220749 2032-02-15 ➤ Sign Up
Crenezumab Brazil 112014019627 2032-02-15 ➤ Sign Up
Crenezumab Canada 2862476 2032-02-15 ➤ Sign Up
Crenezumab China 104114705 2032-02-15 ➤ Sign Up
Crenezumab China 108570468 2032-02-15 ➤ Sign Up
Crenezumab European Patent Office 2814963 2032-02-15 ➤ Sign Up
Crenezumab India 5670DEN2014 2032-02-15 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Argus Health
Deloitte
Queensland Health
Colorcon
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.